Table 1.
Participant demographic characteristics and medical information, stratified by group.
| Variable | All patients (N = 64) | Intervention (N = 33) | Control (N = 31) |
P-value |
|---|---|---|---|---|
| Participant demographic characteristics Age at class (Years) | ||||
| Median (IQR) | 61 (47—72) | 63.5 (54.5—73) | 59.5 (40—71) | .197 |
| Race | ||||
| White | 51 (86.44) | 26 (89.66) | 25 (83.33) | 1.000 |
| Asian | 3 (5.08) | 1 (3.45) | 2 (6.67) | |
| Black or African American | 2 (3.39) | 1 (3.45) | 1 (3.33) | |
| Unknown/not reported | 2 (3.39) | 1 (3.45) | 1 (3.33) | |
| More than one race | 1 (1.69) | 0 (0) | 1 (3.33) | |
| Ethnicity | ||||
| Not Hispanic or Latino | 39 (65.00) | 22 (70.97) | 17 (58.62) | .647 |
| Hispanic or Latino | 8 (13.33) | 3 (9.68) | 5 (17.24) | |
| Other | 8 (13.33) | 3 (9.68) | 5 (17.24) | |
| Unknown/not reported | 5 (8.33) | 3 (9.68) | 2 (6.90) | |
| Marital status | ||||
| Married | 21 (33.33) | 11 (34.38) | 10 (32.26) | .593 |
| Single | 15 (23.81) | 5 (15.63) | 10 (32.26) | |
| Divorced | 14 (22.22) | 9 (28.13) | 5 (16.13) | |
| Widowed | 8 (12.70) | 5 (15.63) | 3 (9.68) | |
| Separated | 3 (4.76) | 1 (3.13) | 2 (6.45) | |
| Living with partner, single | 2 (3.17) | 1 (3.13) | 1 (3.23) | |
| Lives alone | ||||
| No Yes |
37 (58.73) 26 (41.27) |
21 (65.63) 11 (34.38) |
16 (51.61) 15 (48.39) |
.259 |
| Highest level of education completed | ||||
| Post-doctoral | 3 (4.76) | 2 (6.25) | 1 (3.23) | .144 |
| Doctorate | 3 (4.76) | 2 (6.25) | 1 (3.23) | |
| Masters level | 12 (19.05) | 5 (15.63) | 7 (22.58) | |
| University/college | 30 (47.62) | 18 (56.25) | 12 (38.71) | |
| Technical school | 3 (4.76) | 2 (6.25) | 1 (3.23) | |
| Associates degree | 6 (9.52) | 0 (0) | 6 (19.35) | |
| High school | 6 (9.52) | 3 (9.38) | 3 (9.68) | |
| Previous treatment with mental health professional | ||||
| Yes | 32 (56.14) | 17 (65.38) | 15 (48.39) | .198 |
| No | 25 (43.86) | 9 (34.62) | 16 (51.61) | |
| Primary language | ||||
| English | 49 (79.03) | 22 (70.97) | 27 (87.1) | .023a |
| Farsi | 6 (9.68) | 6 (19.35) | 0 (0) | |
| Spanish | 3 (4.84) | 2 (6.45) | 1 (3.23) | |
| Other | 4 (6.45) | 1 (3.23) | 3 (9.68) | |
| Participant medical information | ||||
| Actively receiving chemotherapy treatment | ||||
| No | 20 (37.74) | 11 (36.67) | 9 (39.13) | .854 |
| Yes | 33 (62.26) | 19 (63.33) | 14 (60.87) | |
| Actively receiving non-hormonal targeted therapy treatment | ||||
| No | 9 (30) | 4 (28.57) | 5 (31.25) | 1.000 |
| Yes | 21 (70) | 10 (71.43) | 11 (68.75) | |
| Actively receiving radiation treatment | ||||
| No | 51 (96.23) | 29 (96.67) | 22 (95.65) | 1.000 |
| Yes | 2 (3.77) | 1 (3.33) | 1 (4.35) | |
| Actively receiving hormonal treatment | ||||
| No | 25 (47.17) | 15 (50) | 10 (43.48) | .637 |
| Yes | 28 (52.83) | 15 (50) | 13 (56.52) | |
| History of depression | ||||
| No | 32 (54.24) | 17 (51.52) | 15 (57.69) | .636 |
| Yes | 27 (45.76) | 16 (48.48) | 11 (42.31) | |
| History of anxiety | ||||
| No | 30 (50.85) | 15 (45.45) | 15 (57.69) | .351 |
| Yes | 29 (49.15) | 18 (54.55) | 11 (42.31) | |
| History of bipolar disorder | ||||
| No | 58 (98.31) | 32 (96.97) | 26 (100) | 1.000 |
| Yes | 1 (1.69) | 1 (3.03) | 0 (0) | |
| History of other psychiatric disorder | ||||
| No | 51 (92.73) | 27 (87.1) | 24 (100) | .123 |
| Yes | 4 (7.27) | 4 (12.9) | 0 (0) | |
| Location of metastasis | ||||
| Bone | 29 (51.79) | 15 (48.39) | 14 (56) | |
| Brain | 3 (5.36) | 3 (9.68) | 0 (0) | |
| Liver | 9 (16.07) | 5 (16.13) | 4 (16) | |
| Other | 15 (26.79) | 8 (25.81) | 7 (28) | |
| Months since initial diagnosis* | ||||
| Median (IQR) | 49.08 (21.22-111.58) | 49.08 (21.78-93.26) | 54.19 (15.41-160.97) | .931 |
| Months since initial metastatic disease diagnosis | ||||
| Median (IQR) | 16.02 (5.49-34.93) | 14.98 (5.33-35.36) | 16.02 (11.28-29.18) | .515 |
Data are presented as number of patients (column %) or median (IQR, interquartile range).
P-value is calculated by Wilcoxon rank-sum test continuous variables; and chi-square test or Fisher’s exact test for variables, as appropriate.
aIndicates statistically significant difference
*One patient had a negative value and was not considered.